Correction: Dual antibody-aided mesoporous nanoreactor for H2O2 self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer (Journal of Nanobiotechnology, (2023), 21, 1, (385), 10.1186/s12951-023-02154-0)

Ying Tzu Chen; Ying Xiang Luo; Shih Hsuan Chan; Wen Yi Chiu; Hung Wei Yang

doi:10.1186/s12951-023-02233-2

Correction: Dual antibody-aided mesoporous nanoreactor for H₂O₂ self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer (Journal of Nanobiotechnology, (2023), 21, 1, (385), 10.1186/s12951-023-02154-0)

Ying Tzu Chen, Ying Xiang Luo, Shih Hsuan Chan, Wen Yi Chiu, Hung Wei Yang

生物醫學工程學系

研究成果: Comment/debate › 同行評審

摘要

In this article the statement in the Funding information section was incorrectly given as ‘This research was financially backed by the National Science and Technology Council (NSTC110-2628-B-110-004, NSTC111-2628-B-006-023, NSTC112-2628-B-006-015) and National Health Research Institutes (NHRI-EX112-11226EI), Taiwan’ and should have read ‘This work was financially supported by the National Science and Technology Council (NSTC111- 2628-B-006-023 and NSTC112-2628-B-006-015), National Health Research Institutes (NHRI-EX112- 11226EI), and Kaohsiung Armed Forces General Hospital (KAFGH_D_110025), Taiwan’. The original article [1] has been corrected.

原文	English
文章編號	498
期刊	Journal of Nanobiotechnology
卷	21
發行號	1
DOIs	https://doi.org/10.1186/s12951-023-02233-2
出版狀態	Published - 2023 12月

All Science Journal Classification (ASJC) codes

生物工程
醫藥（雜項）
分子醫學
生物醫學工程
應用微生物與生物技術
藥學科學

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1186/s12951-023-02233-2

其它文件與鏈接

指紋

深入研究「Correction: Dual antibody-aided mesoporous nanoreactor for H₂O₂ self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer (Journal of Nanobiotechnology, (2023), 21, 1, (385), 10.1186/s12951-023-02154-0)」主題。共同形成了獨特的指紋。

引用此

Chen, Y. T., Luo, Y. X., Chan, S. H., Chiu, W. Y., & Yang, H. W. (2023). Correction: Dual antibody-aided mesoporous nanoreactor for H₂O₂ self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer (Journal of Nanobiotechnology, (2023), 21, 1, (385), 10.1186/s12951-023-02154-0). Journal of Nanobiotechnology, 21(1), 文章 498. https://doi.org/10.1186/s12951-023-02233-2

Chen, Ying Tzu ; Luo, Ying Xiang ; Chan, Shih Hsuan 等. / Correction : Dual antibody-aided mesoporous nanoreactor for H₂O₂ self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer (Journal of Nanobiotechnology, (2023), 21, 1, (385), 10.1186/s12951-023-02154-0). 於: Journal of Nanobiotechnology. 2023 ; 卷 21, 編號 1.

@article{6c09175230ef47328b76ace945cd1751,

title = "Correction: Dual antibody-aided mesoporous nanoreactor for H2O2 self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer (Journal of Nanobiotechnology, (2023), 21, 1, (385), 10.1186/s12951-023-02154-0)",

abstract = "In this article the statement in the Funding information section was incorrectly given as {\textquoteleft}This research was financially backed by the National Science and Technology Council (NSTC110-2628-B-110-004, NSTC111-2628-B-006-023, NSTC112-2628-B-006-015) and National Health Research Institutes (NHRI-EX112-11226EI), Taiwan{\textquoteright} and should have read {\textquoteleft}This work was financially supported by the National Science and Technology Council (NSTC111- 2628-B-006-023 and NSTC112-2628-B-006-015), National Health Research Institutes (NHRI-EX112- 11226EI), and Kaohsiung Armed Forces General Hospital (KAFGH_D_110025), Taiwan{\textquoteright}. The original article [1] has been corrected.",

author = "Chen, {Ying Tzu} and Luo, {Ying Xiang} and Chan, {Shih Hsuan} and Chiu, {Wen Yi} and Yang, {Hung Wei}",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = dec,

doi = "10.1186/s12951-023-02233-2",

language = "English",

volume = "21",

journal = "Journal of Nanobiotechnology",

issn = "1477-3155",

publisher = "BioMed Central",

number = "1",

}

Chen, YT, Luo, YX, Chan, SH, Chiu, WY & Yang, HW 2023, 'Correction: Dual antibody-aided mesoporous nanoreactor for H₂O₂ self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer (Journal of Nanobiotechnology, (2023), 21, 1, (385), 10.1186/s12951-023-02154-0)', Journal of Nanobiotechnology, 卷 21, 編號 1, 498. https://doi.org/10.1186/s12951-023-02233-2

Correction: Dual antibody-aided mesoporous nanoreactor for H₂O₂ self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer (Journal of Nanobiotechnology, (2023), 21, 1, (385), 10.1186/s12951-023-02154-0). / Chen, Ying Tzu; Luo, Ying Xiang; Chan, Shih Hsuan 等.
於: Journal of Nanobiotechnology, 卷 21, 編號 1, 498, 12.2023.

研究成果: Comment/debate › 同行評審

TY - JOUR

T1 - Correction

T2 - Dual antibody-aided mesoporous nanoreactor for H2O2 self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer (Journal of Nanobiotechnology, (2023), 21, 1, (385), 10.1186/s12951-023-02154-0)

AU - Chen, Ying Tzu

AU - Luo, Ying Xiang

AU - Chan, Shih Hsuan

AU - Chiu, Wen Yi

AU - Yang, Hung Wei

PY - 2023/12

Y1 - 2023/12

N2 - In this article the statement in the Funding information section was incorrectly given as ‘This research was financially backed by the National Science and Technology Council (NSTC110-2628-B-110-004, NSTC111-2628-B-006-023, NSTC112-2628-B-006-015) and National Health Research Institutes (NHRI-EX112-11226EI), Taiwan’ and should have read ‘This work was financially supported by the National Science and Technology Council (NSTC111- 2628-B-006-023 and NSTC112-2628-B-006-015), National Health Research Institutes (NHRI-EX112- 11226EI), and Kaohsiung Armed Forces General Hospital (KAFGH_D_110025), Taiwan’. The original article [1] has been corrected.

AB - In this article the statement in the Funding information section was incorrectly given as ‘This research was financially backed by the National Science and Technology Council (NSTC110-2628-B-110-004, NSTC111-2628-B-006-023, NSTC112-2628-B-006-015) and National Health Research Institutes (NHRI-EX112-11226EI), Taiwan’ and should have read ‘This work was financially supported by the National Science and Technology Council (NSTC111- 2628-B-006-023 and NSTC112-2628-B-006-015), National Health Research Institutes (NHRI-EX112- 11226EI), and Kaohsiung Armed Forces General Hospital (KAFGH_D_110025), Taiwan’. The original article [1] has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85180152106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85180152106&partnerID=8YFLogxK

U2 - 10.1186/s12951-023-02233-2

DO - 10.1186/s12951-023-02233-2

M3 - Comment/debate

C2 - 38129849

AN - SCOPUS:85180152106

SN - 1477-3155

VL - 21

JO - Journal of Nanobiotechnology

JF - Journal of Nanobiotechnology

IS - 1

M1 - 498

ER -

Chen YT, Luo YX, Chan SH, Chiu WY, Yang HW. Correction: Dual antibody-aided mesoporous nanoreactor for H₂O₂ self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer (Journal of Nanobiotechnology, (2023), 21, 1, (385), 10.1186/s12951-023-02154-0). Journal of Nanobiotechnology. 2023 12月;21(1):498. doi: 10.1186/s12951-023-02233-2